圣诺生物部分董事、高管拟减持公司股份

Core Viewpoint - The announcement from Shengnuo Biotech (688117) indicates that two executives plan to reduce their shareholdings due to personal financial needs [1] Summary by Relevant Sections - Shareholding Reduction Plan - Vice General Manager Ma Zhonggang and Financial Responsible Officer Wu Li intend to reduce their holdings through centralized bidding or block trading [1] - Ma Zhonggang plans to reduce up to 18,800 shares, representing no more than 0.012% of the company's total share capital [1] - Wu Li also plans to reduce up to 18,800 shares, similarly representing no more than 0.012% of the company's total share capital [1]